Clavister (CLAV) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Order intake increased 52% year-over-year, with net sales up 22% and ARR up 9%, reflecting robust demand across all business lines and no reliance on single large orders.
Major defence order of 68 MSEK from BAE Systems and a new partnership agreement with Saab post-quarter, expanding market reach and technological leadership.
Strong demand for European cybersecurity solutions amid geopolitical uncertainty, with growing engagement from partners and customers in critical sectors like energy and defence.
Innovation milestones include a US patent for PASAD AI technology and launch of the Cyber Armour RSG-200 for tactical deployments.
Order backlog increased to SEK 375 million, now extending into 2029, providing strong revenue visibility.
Financial highlights
Net sales reached SEK 55 million (54.8 MSEK), up 22% year-over-year; ARR at 136.6 MSEK, up 9.3%.
Gross margin reached 81.1%, above the 80% target, driven by a favorable sales mix with significant software component.
Adjusted EBITDA margin rose to 16.3% (from 12.3%), with adjusted EBITDA up 60%.
Net result for the quarter was -15.9 MSEK, with EPS at -0.06 SEK.
Financial net debt reduced to -88.4 MSEK from -190.4 MSEK year-over-year.
Outlook and guidance
Targeting at least 20% CAGR sales growth for 2025–2027, with ambition for 2025: EBITDA margin of at least 20%, positive EBIT, and positive operational cash flow.
Strong order backlog and recurring civilian revenues provide a solid foundation for future growth.
Investments in sales, marketing, and technology are prioritized to capture market opportunities while balancing profitability.
Latest events from Clavister
- Record order intake, strong defense wins, and improved financials drive future growth.CLAV
Q4 202512 Feb 2026 - Q2 net sales up 17% to 45M SEK, with strong order intake and positive cash flow.CLAV
Q2 202423 Jan 2026 - First positive EBIT, record margins, and strong order growth drive robust momentum.CLAV
Q3 202416 Jan 2026 - Double-digit growth, robust tech, and major defense contracts position for strong 2025 expansion.CLAV
ABGSC Investor Days12 Jan 2026 - Q4 net sales up 23% and ARR up 14.4%, with improved margins and strong order backlog.CLAV
Q4 202424 Dec 2025 - Order intake up 190% and net sales up 21%, led by major defense and hardware contracts.CLAV
Q1 202522 Nov 2025 - Record profitability and 15% sales growth, but supply delays impact near-term targets.CLAV
Q3 20256 Nov 2025